Springs Rejuvenation, a physician-led regenerative medicine practice, has formally expanded its proprietary Stem 3 Protocol to all five of its United States locations, making exosome-based hair restoration available to patients in New York City, Los Angeles, Austin, Miami, and Atlanta without the need to travel abroad.
The Stem 3 Protocol combines three distinct components delivered in sequence: peptide therapy, exosome hair treatment, and micro follicular unit extraction (micro FUE) performed with 0.9mm instrumentation. The use of 0.9mm instrumentation represents a notably smaller incision diameter than conventional FUE methods, which typically rely on punches ranging from 1.0mm to 1.5mm. The reduced diameter is designed to minimize scalp trauma and support faster tissue recovery.
Exosomes, which are extracellular vesicles derived from stem cells, carry signaling proteins and growth factors that communicate with hair follicle cells. In the context of the Stem 3 Protocol, they are applied to prime the scalp environment before and after the micro FUE procedure, with the goal of extending the active growth phase of the hair cycle and reinforcing follicle density over time. The peptide therapy component is administered as a preparatory measure, intended to optimize cellular conditions in the scalp prior to the exosome and procedural phases.
Until recently, patients seeking non-surgical hair restoration using exosome-based protocols typically pursued treatment at clinics in Europe, Mexico, or Southeast Asia, where regulatory frameworks for regenerative therapies have historically been more permissive. Springs Rejuvenation's multi-city expansion positions the practice as one of the few domestic providers delivering this combination protocol at scale across multiple U.S. states.
"With five active clinic locations, we have now treated patients in every major US time zone under the Stem 3 Protocol," said Dr. Charles Pereyra, MD, Medical Director of Springs Rejuvenation. "Our 0.9mm micro FUE instrumentation paired with exosome hair treatment means patients are no longer choosing between quality and convenience - they can access this level of care in their home city."
Springs Rejuvenation operates each of its five clinics under direct physician supervision. The practice also offers stem cell exosome therapy for joint conditions alongside its hair restoration programs, positioning the clinics as integrated regenerative medicine centers rather than single-specialty providers.
Hair restoration without surgery has become an increasingly documented area within regenerative medicine, with published research examining exosome signaling in dermal papilla cells, the specialized cells responsible for initiating and sustaining hair follicle activity. Springs Rejuvenation applies this science within a structured clinical framework, with each patient undergoing an intake assessment before the Stem 3 Protocol is initiated.
The expansion of the Stem 3 Protocol to five U.S. cities means that patients no longer need to travel abroad for advanced, non-surgical hair restoration. This development may have significant implications for the regenerative medicine industry, as it demonstrates a scalable model for delivering exosome-based therapies within domestic regulatory frameworks. For patients, the availability of this protocol across multiple time zones offers greater convenience and access to cutting-edge care without the expense and logistical challenges of international travel.
For more information, visit Springs Rejuvenation.
